Thrivent Financial for Lutherans Acquires 594 Shares of The Allstate Co. (NYSE:ALL)

Thrivent Financial for Lutherans increased its position in shares of The Allstate Co. (NYSE:ALLFree Report) by 0.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 439,916 shares of the insurance provider’s stock after buying an additional 594 shares during the period. Thrivent Financial for Lutherans owned 0.17% of Allstate worth $83,431,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ALL. Northwest Investment Counselors LLC bought a new position in Allstate in the third quarter worth $28,000. Catalyst Capital Advisors LLC bought a new stake in shares of Allstate during the third quarter valued at approximately $29,000. Versant Capital Management Inc lifted its stake in shares of Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the period. Family Firm Inc. acquired a new position in Allstate during the 2nd quarter valued at about $38,000. Finally, MCF Advisors LLC lifted its stake in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ALL shares. Evercore ISI lifted their price target on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. Barclays lifted their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a research note on Thursday, October 31st. Raymond James raised their target price on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Piper Sandler raised their price objective on Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research report on Friday, August 16th. Finally, Bank of America boosted their price objective on Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $214.19.

Get Our Latest Report on Allstate

Insider Buying and Selling

In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at approximately $15,880,915.68. This trade represents a 50.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 57.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.80% of the stock is owned by corporate insiders.

Allstate Stock Up 0.6 %

Shares of NYSE ALL opened at $196.88 on Monday. The stock has a market capitalization of $52.13 billion, a P/E ratio of 12.75, a PEG ratio of 1.75 and a beta of 0.48. The firm’s 50 day simple moving average is $190.01 and its two-hundred day simple moving average is $176.80. The Allstate Co. has a one year low of $131.65 and a one year high of $201.00. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.40 and a quick ratio of 0.40.

Allstate (NYSE:ALLGet Free Report) last released its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. During the same quarter last year, the business posted $0.81 EPS. The business’s revenue was up 14.7% on a year-over-year basis. As a group, analysts expect that The Allstate Co. will post 16.01 EPS for the current fiscal year.

Allstate Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.87%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Recommended Stories

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.